Cyclacel Pharma (CYCC) Reports Q2 Loss of $1.19

August 10, 2016 4:12 PM EDT
Get Alerts CYCC Hot Sheet
Trade CYCC Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($1.19), versus ($1.01) reported last year. Revenue for the quarter came in at $296 thousand, versus $222 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment